Royalty Pharma (NASDAQ:RPRX – Get Free Report) will issue its quarterly earnings data before the market opens on Tuesday, August 8th. Analysts expect the company to announce earnings of $0.83 per share for the quarter. Parties interested in registering for the company’s conference call can do so using this link. Royalty Pharma (NASDAQ:RPRX – Get […]
Sumitomo Mitsui DS Asset Management Company Ltd grew its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 29.1% in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 28,291 shares of the biopharmaceutical company’s stock after purchasing an additional 6,377 shares during […]
Baillie Gifford & Co. raised its holdings in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 10.5% during the first quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 18,918,750 shares of the biopharmaceutical company’s stock after acquiring an additional 1,799,468 shares during the quarter. Baillie […]
China Universal Asset Management Co. Ltd. grew its stake in Royalty Pharma plc (NASDAQ:RPRX – Free Report) by 34.0% in the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 6,005 shares of the biopharmaceutical company’s stock after acquiring an additional 1,524 shares during […]
Royalty Pharma plc (NASDAQ:RPRX – Get Free Report) CFO Terrance P. Coyne sold 37,500 shares of Royalty Pharma stock in a transaction on Wednesday, July 12th. The stock was sold at an average price of $31.07, for a total value of $1,165,125.00. Following the transaction, the chief financial officer now owns 902,500 shares in the […]